Actin cytoskeleton differentially modulates NF-κB-mediated IL-8 expression in myelomonocytic cells

Biochemical Pharmacology

Volumn 76, Issue 10, 2008, Pages 1214-1228

  Kustermans, Gaelle ^a   El Mjiyad, Nadia ^a   Horion, Julie ^a   Jacobs, Nathalie ^a   Piette, Jacques ^a   Legrand Poels, Sylvie ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Actin cytoskeleton; Cytochalasin D; Interleukin 8; LPS; NF B; TNF

Indexed keywords

ACTIN; CYTOCHALASIN D; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL MEMBRANE; CYTOSKELETON; ENZYME ACTIVATION; GENE EXPRESSION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ACTINS; CYTOSKELETON; GENE EXPRESSION REGULATION; HL-60 CELLS; HUMANS; INTERLEUKIN-8; MONOCYTES; NF-KAPPA B;

EID: 54249085295     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.08.017     Document Type: Article

References (80)

1. Wittmann T., and Waterman-Storer C.M. Cell motility: can Rho GTPases and microtubules point the way?. J Cell Sci 114 Pt21 (2001) 3795-3803
2. Clark K.A., McElhinny A.S., Beckerle M.C., and Gregorio C.C. Striated muscle cytoarchitecture: an intricate web of form and function. Annu Rev Cell Dev Biol 18 (2002) 637-706
3. Friedland J.S., Constantin D., Shaw T.C., and Stylianou E. Regulation of interleukin-8 gene expression after phagocytosis of zymosan by human monocytic cells. J Leukoc Bio 70 3 (2001) 447-454
4. Nanninga N. Cytokinesis in prokaryotes and eukaryotes: common principles and different solutions. Microbiol Mol Biol Rev 65 2 (2001) 319-333
5. Schmidt A., and Hall M.N. Signaling to the actin cytoskeleton. Annu Rev Cell Dev Biol 14 (1998) 305-338
6. Van den Berg A., Freitas J., Keles F., Snoek M., Van Marle J., Jansen H.M., et al. Cytoskeletal architecture differentially controls post-transcriptional processing of IL-6 and IL-8 mRNA in airway epithelial-like cells. Exp Cell Res 312 9 (2006) 1496-1506
7. Miralles F., Posern G., Zaromytidou A.I., and Treisman R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113 3 (2003) 329-342
8. Mack C.P., Somlyo A.V., Hautmann M., Somlyo A.P., and Owens G.K. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem 276 1 (1999) 341-347
9. Rivas F.V., O'Keefe J.P., Alegre M.L., and Gajewski T.F. Actin cytoskeleton regulates calcium dynamics and NFAT nuclear duration. Mol Cell Biol 24 4 (2004) 1628-1639
10. Holsinger L.J., Graef I.A., Swat W., Chi T., Bautista D.M., Davidson L., et al. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr Biol 8 10 (1998) 563-572
11. Fomproix N., and Percipalle P. An actin-myosin complex on actively transcribing genes. Exp Cell Res 294 1 (2004) 140-148
12. Hu P., Wu S., and Hernandez N. A role for beta-actin in RNA polymerase III transcription. Genes Dev 18 24 (2004) 3010-3015
13. Hofmann W.A., Stojiljkovic L., Fuchsova B., Vargas G.M., Mavrommatis E., Philimonenko V., et al. Actin is part of pre-initiation complexes and is necessary for transcription by RNA polymerase II. Nat Cell Biol 6 11 (2004) 1094-1101
14. Peppelenbosch M., Boone E., Jones G.E., van Deventer S.J., Haegeman G., Fiers W., et al. Multiple signal transduction pathways regulate TNF-induced actin reorganization in macrophages: inhibition of Cdc42-mediated filopodium formation by TNF. J Immunol 162 2 (1999) 837-845
15. Singh R., Wang B., Shirvaikar A., Khan S., Kamat S., Schelling J.R., et al. The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. J Clin Invest 103 11 (1999) 1561-1570
16. Chakravortty D., and Nanda Kumar K.S. Bacterial lipopolysaccharide induces cytoskeletal rearrangement in small intestinal lamina propria fibroblasts: actin assembly is essential for lipopolysaccharide signaling. Biochim Biophys Acta 1500 1 (2000) 125-136
17. Royle M.C., Totemeyer S., Alldridge L.C., Maskell D.J., and Bryant C.E. Stimulation of Toll-like receptor 4 by lipopolysaccharide during cellular invasion by live Salmonella typhimurium is a critical but not exclusive event leading to macrophage responses. J Immunol 170 11 (2003) 5445-5454
18. Reyes-Reyes M., Mora N., Gonzalez G., and Rosales C. beta1 and beta2 integrins activate different signalling pathways in monocytes. Biochem J 363 Pt2 (2002) 273-280
19. Huang S., Chen L.Y., Zuraw B.L., Ye R.D., and Pan Z.K. Chemoattractant-stimulated NF-kappaB activation is dependent on the low molecular weight GTPase RhoA. J Biol Chem 276 44 (2001) 40977-40981
20. Kustermans G., El Benna J., Piette J., and Legrand-Poels S. Perturbation of actin dynamics induces NF-kappaB activation in myelomonocytic cells through an NADPH oxidase-dependent pathway. Biochem J 387 Pt2 (2005) 531-540
21. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16 (1998) 225-260
22. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev 18 18 (2004) 2195-2224
23. Martin M.U., and Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta 1592 3 (2002) 265-280
24. Devin A., Cook A., Lin Y., Rodriguez Y., Kelliher M., and Liu Z. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12 4 (2000) 419-429
25. Akira S., and Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4 7 (2004) 499-511
26. O'Neill L.A. How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 18 1 (2006) 3-9
27. Zandi E., Rothwarf D.M., Delhase M., Hayakaw M., and Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91 2 (1997) 243-252
28. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93 7 (1998) 1231-1240
29. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18 (2000) 621-663
30. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell (Cambridge, Mass) 109 (2002) S81-S96
31. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 18 (2000) 217-242
32. Chen L.F., and Greene W.C. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5 5 (2004) 392-401
33. Perkins N.D. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25 51 (2006) 6717-6730
34. Chen L.F., Mu Y., and Greene W.C. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J 21 23 (2002) 6539-6548
35. Zhong H., Voll R.E., and Gosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1 5 (1998) 661-671
36. Chen L.F., Williams S.A., Mu Y., Nakano H., Duerr J.M., Buckbinder L., et al. NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol 25 18 (2005) 7966-7975
37. Bannister A.J., and Miska E.A. Regulation of gene expression by transcription factor acetylation. Cell Mol Life Sci 57 8-9 (2000) 1184-1192
38. Kuo M.H., and Allis C.D. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20 8 (1998) 615-626
39. Gerritsen M.E., Williams A.J., Neish A.S., Moore S., Shi Y., and Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 94 7 (1997) 2927-2932
40. Josse C., Boelaert J.R., Best-Belpomme M., and Piette J. Importance of post-transcriptional regulation of chemokine genes by oxidative stress. Biochem J 360 2 (2001) 321-333
41. Legrand-Poels S., Kustermans G., Bex F., Kremmer E., Kufer T.A., and Piette J. Modulation of Nod2-dependent NF-kappaB signaling by the actin cytoskeleton. J Cell Sci 120 Pt7 (2007) 1299-1310
42. Volanti C., Matroule J.Y., and Piette J. Involvement of oxidative stress in NF-kappaB activation in endothelial cells treated by photodynamic therapy. Photochem Photobiol 75 1 (2002) 36-45
43. Volanti C., Hendrickx N., Van Lint C., Matroule J.Y., Agostinis P., and Piette J. Distinct transduction mechanisms of cyclooxygenase 2 gene activation in tumour cells after photodynamic therapy. Oncogene 24 18 (2005) 2981-2991
44. Horion J., Gloire G., El Mjiyad N., Quivy V., Vermeulen L., Vanden Berghe W., et al. Histone deacetylase inhibitor trichostatin A sustains sodium pervanadate-induced NF-kappaB activation by delaying IkappaBalpha mRNA resynthesis: comparison with tumor necrosis factor alpha. J Biol Chem 282 21 (2007) 15383-15393
45. Sampath P., and Pollard T.D. Effects of cytochalasin, phalloidin, and pH on the elongation of actin filaments. Biochemistry 30 7 (1991) 1073-1080
46. Uematsu Y., Kogo Y., and Ohishi I. Disassembly of actin filaments by botulinum C2 toxin and actin-filament-disrupting agents induces assembly of microtubules in human leukaemia cell lines. Biol Cell 99 3 (1999) 141-150
47. Moser B., and Willimann K. Chemokines: role in inflammation and immune surveillance. Ann Rheum Dis 63 Suppl 2 (2004) ii84-ii89
48. Rottman J.B. Key role of chemokines and chemokine receptors in inflammation, immunity, neoplasia, and infectious disease. Vet Pathol 36 5 (1999) 357-367
49. Mahalingam S., and Karupiah G. Chemokines and chemokine receptors in infectious diseases. Immunol Cell Biol 77 (1999) 469-475
50. Villarete L.H., and Remick D.G. Transcriptional and post-transcriptional regulation of interleukin-8. Am J Pathol 149 5 (1996) 1685-1693
51. Saitoh S.I., and Miyake K. Mechanism regulating cell surface expression and activation of Toll-like receptor 4. Chem Rec 6 6 (2006) 311-319
52. Latz E., Visintin A., Lien E., Fitzgerald K.A., Monks B.G., Kurt-Jones E.A., et al. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem 277 38 (2002) 47834-47843
53. Soldati T., and Schliwa M. Powering membrane traffic in endocytosis and recycling. Nat Rev Mol Cell Biol 7 12 (2006) 897-908
54. Husebye H., Halaas O., Stenmark H., Tunheim G., Sandanger O., Bogen B., et al. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J 25 4 (2006) 683-692
55. Kagan J.C., Su T., Horng T., Chow A., Akira S., and Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 9 4 (2008) 361-368
56. Jamaluddin M., Wang S., Boldogh I., Tian B., and Brasier A.R. TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. Cell Signal 19 7 (2007) 1419-1433
57. Vermeulen L., De Wilde G., Van Damme P., Vanden Berghe W., and Haegeman G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 22 6 (2003) 1313-1324
58. Yang F., Tang E., Guan K., and Wang C.Y. IKKβ plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J Immunol 170 11 (2003) 5630-5635
59. Sakurai H., Chiba H., Miyoshi H., Sugita T., and Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274 43 (1999) 30353-30356
60. Iizuka M., and Smith M.M. Functional consequences of histone modifications. Curr Opin Genet Dev 13 2 (2003) 154-160
61. Schafer D.A. Coupling actin dynamics and membrane dynamics during endocytosis. Curr Opin Cell Biol 14 1 (2002) 76-81
62. Lamaze C., Fujimoto L.M., Yin H.L., and Schmid S.L. The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells. J Biol Chem 272 33 (1997) 20332-20335
63. Fujimoto L.M., Roth R., Heuser J.E., and Schmid S.L. Actin assembly plays a variable, but not obligatory role in receptor-mediated endocytosis in mammalian cells. Traffic 1 2 (2000) 161-171
64. Deak M., Clifton A.D., Lucocq L.M., and Alessi D.R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J 17 15 (1998) 4426-4441
65. Adachi M., Fukuda M., and Nishida E. Two co-existing mechanisms for nuclear import of MAP kinase: passive diffusion of a monomer and active transport of a dimer. EMBO J 18 19 (1999) 5347-5358
66. Adachi M., Fukuda M., and Nishida E. Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism. J Cell Biol 148 5 (2000) 849-856
67. Smith E.R., Smedberg J.L., Rula M.E., and Xu X.X. Regulation of Ras-MAPK pathway mitogenic activity by restricting nuclear entry of activated MAPK in endoderm differentiation of embryonic carcinoma and stem cells. J Cell Biol 164 (2004) 689-699
68. Winzen R., Kracht M., Ritter B., Wilhelm A., Chen C.Y., Shyu A.B., et al. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 18 18 (1999) 4969-4980
69. Chen C.Y., and Shyu A.B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20 11 (1995) 465-470
70. Bevilacqua A., Ceriani M.C., Capaccioli S., and Nicolin A. Post-transcriptional regulation of gene expression by degradation of messenger RNAs. J Cell Physiol 195 3 (2003) 356-372
71. Holtmann H., Winzen R., Holland P., Eickemeier S., Hoffmann E., Wallach D., et al. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol 19 10 (1999) 6742-6753
72. Carballo E., Lai W.S., and Blackshear P.J. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281 5379 (1998) 1001-1005
73. Brennan C.M., and Steitz J.A. HuR and mRNA stability. Cell Mol Life Sci 58 2 (2001) 266-277
74. Brook M., Sully G., Clark A.R., and Saklatvala J. Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade. FEBS Lett 483 1 (2000) 57-61
75. Pages G., Berra E., Milanini J., Levy A.P., and Pouyssegur J. Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. J Biol Chem 275 34 (2000) 26484-26491
76. Rutault K., Hazzalin C.A., and Mahadevan L.C. Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-alpha) mRNA induction. Evidence for selective destabilization of TNF-alpha transcripts. J Biol Chem 276 9 (2001) 6666-6674
77. Dean J.L., Wait R., Mahtani K.R., Sully G., Clark A.R., and Saklatvala J. The 3′ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol Cell Biol 21 3 (2001) 721-730
78. Henics T., Nagy E., and Szekeres-Bartho J. Interaction of AU-rich sequence binding proteins with actin: possible involvement of the actin cytoskeleton in lymphokine mRNA turnover. J Cell Physiol 173 1 (1997) 19-27
79. Kim Y.B., Yu J., Lee S.Y., Lee M.S., Ko S.G., Ye S.K., et al. Cell adhesion status-dependent histone acetylation is regulated through intracellular contractility-related signaling activities. J Biol Chem 280 31 (2005) 28357-28364
80. Vollmer K.L., Alberts J.S., Carper H.T., and Mandell G.L. Tumor necrosis factor-alpha decreases neutrophil chemotaxis to N-formyl-1-methionyl-1-leucyl-1-phenylalanine: analysis of single cell movement. J Leukoc Biol 52 6 (1992) 630-636